{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:58:04Z","timestamp":1777629484197,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xphs.2026.104219","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:16:42Z","timestamp":1771949802000},"page":"104219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cocrystals of telmisartan with ascorbic acid: Enhanced solubility and antiviral potency against Japanese encephalitis virus"],"prefix":"10.1016","volume":"115","author":[{"given":"Varaprasad Rao","family":"Regu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-3040","authenticated-orcid":false,"given":"Ankita","family":"Datey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tompe Krishna","family":"Vitthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0035-2554","authenticated-orcid":false,"given":"Ranjit Prasad","family":"Swain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5209-3176","authenticated-orcid":false,"given":"Shivam","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8378-1014","authenticated-orcid":false,"given":"Soma","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2411-7292","authenticated-orcid":false,"given":"Bharat Bhusan","family":"Subudhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2026.104219_bib0001","first-page":"677","article-title":"Telmisartan and cardioprotection","volume":"7","author":"Akhrass","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.xphs.2026.104219_bib0002","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.3390\/cancers15123199","article-title":"Repurposing of chronically used drugs in cancer therapy: a chance to grasp","volume":"15","author":"Hijazi","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.xphs.2026.104219_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102039","article-title":"Peroxisome proliferator-activated receptors: key regulators of tumor progression and growth","volume":"47","author":"Asgharzadeh","year":"2024","journal-title":"Transl Oncol"},{"issue":"41","key":"10.1016\/j.xphs.2026.104219_bib0004","doi-asserted-by":"crossref","first-page":"67150","DOI":"10.18632\/oncotarget.11567","article-title":"Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.xphs.2026.104219_bib0005","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/biology11010114","article-title":"PPAR ligands induce antiviral effects targeting perturbed lipid metabolism during SARS-CoV-2, HCV, and HCMV infection","volume":"11","author":"Fantacuzzi","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.xphs.2026.104219_bib0006","unstructured":"LV S, DS S, A G, B K. Japanese encephalitis. StatPearls. Published online 2025. Accessed April 19, 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/29262148\/"},{"issue":"1","key":"10.1016\/j.xphs.2026.104219_bib0007","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01489-21","article-title":"Telmisartan restricts chikungunya virus infection in vitro and in vivo through the AT1\/PPAR-\u03b3\/MAPKs pathways","volume":"66","author":"De","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.xphs.2026.104219_bib0008","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10571-017-0554-5","article-title":"Roles of peroxisome proliferator-activated receptor gamma on brain and peripheral inflammation","volume":"38","author":"Villapol","year":"2018","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104219_bib0009","first-page":"1","article-title":"Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission","volume":"10","author":"Lage","year":"2024","journal-title":"npj Parkinson\u2019s Dis"},{"issue":"16","key":"10.1016\/j.xphs.2026.104219_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168876","article-title":"PPAR Gamma and viral infections of the brain","volume":"22","author":"Layrolle","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104219_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0683-7","article-title":"Type-1 angiotensin receptor signaling in central nervous system myeloid cells is pathogenic during fatal alphavirus encephalitis in mice","volume":"13","author":"Blakely","year":"2016","journal-title":"J Neuroinflamm"},{"issue":"3","key":"10.1016\/j.xphs.2026.104219_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.70040","article-title":"Role of angiotensin II in Venezuelan equine encephalitis: narrative review","volume":"35","author":"Pedrea\u00f1ez","year":"2025","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.xphs.2026.104219_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03003-24","article-title":"Telmisartan, an anti-hypertensive drug, impedes JEV infection, possibly via the AT1\/PPAR\u03b3 axis","author":"Datey","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.xphs.2026.104219_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116842","article-title":"Innovative medicinal chemistry strategies for enhancing drug solubility","volume":"279","author":"He","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"6-7","key":"10.1016\/j.xphs.2026.104219_bib0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/17460794.2024.2360833","article-title":"Cocrystals development: an approach to improve antiviral efficacy","volume":"19","author":"Regu","year":"2024","journal-title":"Fut Virol"},{"key":"10.1016\/j.xphs.2026.104219_bib0016","article-title":"Pharmaceutical cocrystals: unlocking the potential of challenging drug candidates","volume":"104","author":"Pantwalawalkar","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2026.104219_bib0017","unstructured":"Simon L V., Sandhu DS, Goyal A, Kruse B. Japanese encephalitis. StatPearls. Published online August 28, 2023. Accessed August 1, 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470423\/"},{"issue":"4","key":"10.1016\/j.xphs.2026.104219_bib0018","first-page":"595","article-title":"Inhibition of multiplication of herpes simplex virus by caffeic acid","volume":"28","author":"Ikeda","year":"2011","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.xphs.2026.104219_bib0019","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/B978-0-323-89835-5.00028-4","article-title":"Vitamin C and neuroinflammation","author":"Marino","year":"2023","journal-title":"Vit Miner Neurol Disord"},{"issue":"9","key":"10.1016\/j.xphs.2026.104219_bib0020","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1021\/cg300784v","article-title":"Pharmaceutical cocrystals of niclosamide","volume":"12","author":"Sanphui","year":"2012","journal-title":"Cryst Growth Des"},{"issue":"11","key":"10.1016\/j.xphs.2026.104219_bib0021","doi-asserted-by":"crossref","first-page":"15380","DOI":"10.1021\/acsomega.8b02144","article-title":"Enhanced Solubility of Telmisartan Phthalic Acid Cocrystals within the pH Range of a Systemic Absorption Site","volume":"3","author":"Kundu","year":"2018","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.xphs.2026.104219_bib0022","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s41745-017-0026-4","article-title":"X-Ray crystallography and its role in understanding the physicochemical properties of pharmaceutical cocrystals","volume":"97","author":"Aitipamula","year":"2017","journal-title":"J Indian Inst Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104219_bib0023","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1021\/cg1009237","article-title":"A comparison of cocrystal structure solutions from powder and single crystal techniques","volume":"10","author":"Lapidus","year":"2010","journal-title":"Cryst Growth Des"},{"issue":"8","key":"10.1016\/j.xphs.2026.104219_bib0024","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s11095-023-03532-x","article-title":"Optimisation of pharmaceutical cocrystal dissolution performance through a synergistic precipitation inhibition","volume":"40","author":"Shi","year":"2023","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2026.104219_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124789","article-title":"A potential cocrystal strategy to tailor in-vitro dissolution and improve Caco-2 permeability and oral bioavailability of berberine","volume":"666","author":"Chen","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104219_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104325","article-title":"Molecular epidemiology of Japanese encephalitis virus in pig population of Odisha, Assam and Manipur states of India","volume":"83","author":"Datey","year":"2020","journal-title":"Infect Genet Evol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104219_bib0027","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/2211738508666200607181727","article-title":"Simultaneous determination of telmisartan and pitavastatin calcium in intestinal perfusate by HPLC: application to intestinal absorption interaction study","volume":"8","author":"Wang","year":"2020","journal-title":"Pharm Nanotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104219_bib0028","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00705-020-04852-8","article-title":"Inhibition of transient receptor potential vanilloid 1 (TRPV1) channel regulates chikungunya virus infection in macrophages","volume":"166","author":"Sanjai Kumar","year":"2021","journal-title":"Arch Virol"},{"issue":"8","key":"10.1016\/j.xphs.2026.104219_bib0029","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.apsb.2021.03.030","article-title":"Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications","volume":"11","author":"Guo","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10.1016\/j.xphs.2026.104219_bib0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2006.07.010","article-title":"Antiviral effect of octyl gallate against DNA and RNA viruses","volume":"73","author":"Uozaki","year":"2007","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.xphs.2026.104219_bib0031","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/14787210.2020.1706483","article-title":"The antiviral properties of vitamin C","volume":"18","author":"Colunga Biancatelli","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"26","key":"10.1016\/j.xphs.2026.104219_bib0032","doi-asserted-by":"crossref","first-page":"28776","DOI":"10.1021\/acsomega.4c03172","article-title":"First-order derivative spectrophotometry for simultaneous determination of vitamin C and nicotinamide: application in quantitative analysis of cocrystals","volume":"9","author":"Balbinot Filho","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.xphs.2026.104219_bib0033","article-title":"Novel curcumin ascorbic acid cocrystal for improved solubility","volume":"61","author":"Pantwalawalkar","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"issue":"13","key":"10.1016\/j.xphs.2026.104219_bib0034","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1039\/C8CE01075G","article-title":"Role of hydrogen bonding in cocrystals and coamorphous solids: indapamide as a case study","volume":"21","author":"Allu","year":"2019","journal-title":"CrystEngComm"},{"issue":"18","key":"10.1016\/j.xphs.2026.104219_bib0035","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1039\/C7RA00298J","article-title":"Thermal behavior and molecular mobility in the glassy state of three anti-hypertensive pharmaceutical ingredients","volume":"7","author":"Moura Ramos","year":"2017","journal-title":"RSC Adv"},{"issue":"7","key":"10.1016\/j.xphs.2026.104219_bib0036","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1021\/acs.cgd.9b01253","article-title":"Calorimetric determination of cocrystal thermodynamic stability: sulfamethazine-salicylic acid case study","volume":"20","author":"Sv\u00e4rd","year":"2020","journal-title":"Cryst Growth Des"},{"issue":"17-18","key":"10.1016\/j.xphs.2026.104219_bib0037","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.phytochem.2009.09.028","article-title":"Covalent interaction of ascorbic acid with natural products","volume":"70","author":"Kesinger","year":"2009","journal-title":"Phytochemistry"},{"issue":"36","key":"10.1016\/j.xphs.2026.104219_bib0038","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1039\/C4CE00797B","article-title":"Cocrystals of telmisartan: characterization, structure elucidation, in vivo and toxicity studies","volume":"16","author":"Chadha","year":"2014","journal-title":"CrystEngComm"},{"issue":"7","key":"10.1016\/j.xphs.2026.104219_bib0039","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s11696-019-00720-1","article-title":"Effect of surfactants and polymers on morphology and particle size of telmisartan in ultrasound-assisted anti-solvent crystallization","volume":"73","author":"Sharma","year":"2019","journal-title":"Chem Pap"},{"issue":"1","key":"10.1016\/j.xphs.2026.104219_bib0040","first-page":"163","article-title":"Effect of process parameters on particle size and morphology of telmisartan in anti-solvent crystallization","volume":"102","author":"Sharma","year":"2021","journal-title":"J Inst Eng"},{"issue":"10","key":"10.1016\/j.xphs.2026.104219_bib0041","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/macp.1979.021801023","article-title":"Relation between crystallinity degree and stability in solid state of high molecular weight poly(ethylene oxide)s","volume":"180","author":"Bortel","year":"1979","journal-title":"Die Makromol Chem"},{"key":"10.1016\/j.xphs.2026.104219_bib0042","doi-asserted-by":"crossref","first-page":"104","DOI":"10.22159\/ajpcr.2020.v13i3.36541","article-title":"Novel pharmaceutical cocrystal of telmisartan and hydrochlorothiazide","volume":"13","author":"Kulkarni","year":"2020","journal-title":"Asian J Pharm Clin Res"},{"key":"10.1016\/j.xphs.2026.104219_bib0043","unstructured":"IJPI\u2019s JPharm Cosmetol IsolatEvaluation of natural superdisintegrant from plantago ovata in MDTs of telmisartan. Accessed 24 January 2026. https:\/\/www.researchgate.net\/publication\/263576634_IJPI\u2019s_Journal_of_Pharmaceutics_and_Cosmetology_Isolation_and_Evaluation_of_Natural_Superdisintegrant_from_Plantago_Ovata_in_MDTs_of_Telmisartan"},{"key":"10.1016\/j.xphs.2026.104219_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2024.135662","article-title":"Complexation of telmisartan with cyclodextrins as a tool of solubility enhancement: a comparative analysis of influence of the cyclodextrin type and method of solid dispersion preparation","volume":"705","author":"Sharapova","year":"2025","journal-title":"Colloids Surf A"},{"issue":"3","key":"10.1016\/j.xphs.2026.104219_bib0045","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1208\/s12249-021-01952-9","article-title":"Preparation and evaluation of co-amorphous formulations of telmisartan\u2014amino acids as a potential method for solubility and dissolution enhancement","volume":"22","author":"Khanfar","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"10.1016\/j.xphs.2026.104219_bib0046","doi-asserted-by":"crossref","first-page":"15380","DOI":"10.1021\/acsomega.8b02144","article-title":"Enhanced solubility of telmisartan phthalic acid cocrystals within the pH range of a systemic absorption site","volume":"3","author":"Kundu","year":"2018","journal-title":"ACS Omega"},{"issue":"48","key":"10.1016\/j.xphs.2026.104219_bib0047","doi-asserted-by":"crossref","first-page":"18216","DOI":"10.3748\/wjg.v20.i48.18216","article-title":"Motility patterns of ex vivo intestine segments depend on perfusion mode","volume":"20","author":"Schreiber","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.xphs.2026.104219_bib0048","unstructured":"Micardis (telmisartan) Tablets, 20 mg, 40 mg and 80 mg fda access data - Google Search. Accessed 19 April 2025. https:\/\/www.google.com\/search?q=Micardis+(telmisartan)+Tablets%2C+20+mg%2C+40+mg+and+80+mg+fda+access+data&oq=Micardis+(telmisartan)+Tablets%2C+20+mg%2C+40+mg+and+80+mg+fda+access+data&gs_lcrp=EgZjaHJvbWUyBggAEEUYOTIHCAEQIRiPAjIHCAIQIRiPAtIBCDYzMDhqMGo0qAIAsAIB&sourceid=chrome&ie=UTF-8"},{"issue":"8","key":"10.1016\/j.xphs.2026.104219_bib0049","article-title":"Polymorphism of ORM1 Is Associated with the Pharmacokinetics of Telmisartan","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.xphs.2026.104219_bib0050","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.nucmedbio.2012.06.012","article-title":"Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques","volume":"39","author":"Noda","year":"2012","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.xphs.2026.104219_bib0051","article-title":"An outlook on permeability escalation through cocrystallization for developing pharmaceuticals with improved biopharmaceutical properties","volume":"76","author":"Pandey","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104219_bib0052","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1039\/D0CE01316A","article-title":"Enhanced solubility, permeability, and tabletability of nicorandil by salt and cocrystal formation","volume":"23","author":"Mannava","year":"2021","journal-title":"CrystEngComm"},{"issue":"10","key":"10.1016\/j.xphs.2026.104219_bib0053","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s11095-021-03116-7","article-title":"Effect of coformer selection on in vitro and in vivo performance of adefovir dipivoxil cocrystals","volume":"38","author":"Li","year":"2021","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2026.104219_bib0054","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.nutr.25.050304.092647","article-title":"Regulation of vitamin C transport","volume":"25","author":"Wilson","year":"2005","journal-title":"Annu Rev Nutr"},{"issue":"6","key":"10.1016\/j.xphs.2026.104219_bib0055","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-018-0270-1","article-title":"Conjugation to ascorbic acid enhances brain availability of losartan carboxylic acid and protects against Parkinsonism in rats","volume":"20","author":"Subudhi","year":"2018","journal-title":"AAPS J"},{"issue":"1-2","key":"10.1016\/j.xphs.2026.104219_bib0056","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpharm.2011.05.001","article-title":"Targeting SVCT for enhanced drug absorption: Synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir","volume":"414","author":"Luo","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104219_bib0057","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.2147\/IJN.S447721","article-title":"Revolutionizing antiviral therapeutics: unveiling innovative approaches for enhanced drug efficacy","volume":"19","author":"Megantara","year":"2024","journal-title":"Int J Nanomed"},{"issue":"1","key":"10.1016\/j.xphs.2026.104219_bib0058","article-title":"Predicting drug combination index and simulating the network-regulation dynamics by mathematical modeling of drug-targeted EGFR-ERK signaling pathway","volume":"7","author":"Huang","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.xphs.2026.104219_bib0059","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1291\/hypres.31.657","article-title":"Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of the incipient to overt: angiotensin II blocker, telmisartan, investigation on type 2 diabetic nephropathy","volume":"31","author":"Makino","year":"2008","journal-title":"Hypertens Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:27:29Z","timestamp":1777429649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0022354926000687"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104219","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cocrystals of telmisartan with ascorbic acid: Enhanced solubility and antiviral potency against Japanese encephalitis virus","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104219"}}